If patients going into surgery were assessed for the risk of opioid-induced respiratory depression (OIRD), how many adverse events and death would be prevented?
Would such an assessment have placed in the at risk category patients like John Lachance (who underwent surgery to repair a torn rotator cuff) or Leah Coufal (who had elective surgery to repair a condition called pectus carinatum)?
Researchers at St. Joseph Mercy Ann Arbor, Ypsilanti, MI have developed a new risk index tool that may allow hospital staff to identify surgical candidates who are at risk for OIRD.
Nicole Humbert, PharmD (Inpatient Pharmacist, St. Joseph Mercy Health System) and her colleagues did a retrospective analysis to determine contributing iatrogenic factors (opioid/sedative doses) that may contribute to oversedation and/or respiratory depression in patients who receive naloxone for OIRD. They presented their research at PAINWeek 2015.
The Physician-Patient Alliance for Health & Safety will be interviewing Ms. Humbert and fellow researcher Cheryl Genord, RPh about their research.
If you would like to receive a copy of the interview which will also be available on iTunes and YouTube, please complete the information below:
[contact-form-7 id=”3944″ title=”Contact form 1″]